Thymidylate synthase protein expression in advanced colon cancer: Correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil

Clinical Cancer Research

Volumn 5, Issue 8, 1999, Pages 1996-1999

  Cascinu, Stefano ^a   Aschele, Carlo ^b   Barni, Sandro ^d   Debernardis, Domizia ^b   Baldo, Chiara ^b   Tunesi, Gianni ^c   Catalano, Vincenzo ^a   Staccioli, Maria Pia ^a   Brenna, Ambrogio ^d   Muretto, Pietro ^a   Catalano, Giuseppina ^a  

^a Azienda Ospedaliera Osp S S   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c GALLIERA HOSPITAL   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; THYMIDYLATE SYNTHASE;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RECURRENCE; COLON CANCER; CORRELATION FUNCTION; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COLONIC NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; THYMIDYLATE SYNTHASE; TREATMENT OUTCOME;

EID: 6544276581     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Seymour, M. T. Colorectal cancer: treatment of advanced disease. Cancer Treat. Rev., 24: 119-131, 1998.
2. Peters, G. J., van der Wilt, C. L., van Triest, B., Codacci-Pisanelli, G., Johnston, P. G., van Groeningen, C. J., and Pinedo, H. M. Thymidylate synthase and drug resistance. Eur. J. Cancer, 31A: 1299-1305, 1995.
3. Leichman, L., Lenz, H. J., Leichman, C. G., Groshen, S., Danenberg, K., Baranda, J., Spears, C. P., Boswell, W., Silberman, H., Ortega, A., Stain, S., Beart, R., and Danenberg, P. Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial. Eur. J. Cancer, 31A: 1306-1310, 1995.
4. Peters, G. J., van der Wilt, C. L., van Groeningen, C. J., Smid, K., Meijer, S., and Pinedo, H. M. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. J. Clin. Oncol., 12: 2035-2042, 1994.
5. Johnston, P. G., Lenz, H. J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., and Leichman, L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res., 55: 1407-1412, 1995.
6. Leichman, C. G., Lenz, H. J., Leichman, L., Danenberg, K., Baranda, J., Groshen, S., Boswell, W., Metzger, R., Tan, M., and Danenberg, P. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J. Clin. Oncol., 15: 3223-3229, 1997.
7. Aschele, C., Debernardis, D., Casazza, S., Antonelli, A., Tunesi, G., Baldo, C., Lionetto, R., Maley, F., and Sobrero, A. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy. J. Clin. Oncol., in press, 1999.
8. Aschele, C., Sobrero, A., Faderan, M. A., and Bertino, J. R. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. Cancer Res., 52: 1855-1864, 1992.
9. Gorlick, R., Metzger, R., Danenberg, K. D., Salanga, D., Miles, J. S., Longo, G. S. A., Fu, J., Banerjee, D., Klimstra, D., Jhanwar, S., Danenberg, P. V., Kemeny, N., and Bertino, J. R. Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J. Clin. Oncol., 16: 1465-1469, 1998.
10. Labianca, R., Cascinu, S., Frontini, L., Barni, S., Fiorentini, G., Comella, G., Zaniboni, A., Gottardi, O., Arnoldi, E., Oliani, C., Duro, M., Pavanato, G., Martignoni, G., Raina, A., Piazza, E., Dallavalle, G., Valsecchi, R., Pancera, G., and Luporini, G. High versus low dose levo leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A GISCAD phase III study. Ann. Oncol., 8: 169-174, 1997.
11. Miller, A. B., Hoodgstraten, B., Staquet, M., and Winkler, A. Reporting results of cancer treatment. Cancer (Phila.), 47: 207-214, 1981.
12. Tong, Y., Liu-Chen, X., Ercikan-Abali, E. A., Capiaux, G. M., Zhao, S. C., Banerjee, D., and Bertino, J. R. Isolation and characterization of thymitaq (AG337) and 5-fluoro-2-deoxyuridilate-resistant mutants of human thymidylate synthase from ethyl methansulfonate-exposed human sarcoma HT1080 cells. J. Biol. Chem., 273: 11611-11618, 1998.
13. Benson, A. B., Catalano, P. J., Rao, S., Haller, D. G., O'Dwyer, P. J., Allegra, C. J., and Johnston, P. G. Thymidylate synthase expression as a predictor for response to a 5-fluorouracil-based therapy and survival for patients with resected colon or advanced colorectal cancer. Proc. Am. Soc. Clin. Oncol., 16: 917, 1997.
14. Findlay, M. P. N., Cunningham, D., Morgan, G., Clinton, S., Hardcastle, A., and Aherne, G. W. Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy. Br. J. Cancer, 75: 903-909, 1997.